A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus

References

• Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–62. doi:10.1016/S1473-3099(05)70295-4.
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–32. doi:10.1056/NEJM199808203390806.
   PubMed Web of Science ®Google Scholar
• Fluit AC. Livestock-associated Staphylococcus aureus. Clin Microbiol Infect. 2012;18:735–44. doi:10.1111/j.1469-0691.2012.03846.x.
   PubMed Web of Science ®Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–74. doi:10.1056/NEJMoa055356.
   PubMed Web of Science ®Google Scholar
• Mandal SM, Ghosh AK, Pati BR. Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents. Am J Infect Control. 2015;43:e87–8. doi:10.1016/j.ajic.2015.08.015.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol. 2007;5:491–504. doi:10.1038/nrmicro1688.
   PubMed Web of Science ®Google Scholar
• Giersing BK, Dastgheyb SS, Modjarrad K, et al. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine. 2016;34:2962–6. doi:10.1016/j.vaccine.2016.03.110.
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Fontana MR, Soldaini E, et al. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad Sci U S A. 2015;112:3680–5.
   PubMed Web of Science ®Google Scholar
• Frey J. Biological safety concepts of genetically modified live bacterial vaccines. Vaccine. 2007;25:5598–605. doi:10.1016/j.vaccine.2006.11.058.
   PubMed Web of Science ®Google Scholar
• Hoiseth SK, Stocker BA. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981;291:238–9. doi:10.1038/291238a0.
   PubMed Web of Science ®Google Scholar
• Karnell A, Stocker BA, Katakura S, et al. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies. Vaccine. 1992;10:389–94. doi:10.1016/0264-410X(92)90069-V.
   PubMed Web of Science ®Google Scholar
• Sizemore DR, Branstrom AA, Sadoff JC. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science. 1995;270:299–302. doi:10.1126/science.270.5234.299.
   PubMed Web of Science ®Google Scholar
• Guleria I, Teitelbaum R, McAdam RA, et al. Auxotrophic vaccines for tuberculosis. Nat Med. 1996;2:334–7. doi:10.1038/nm0396-334.
   PubMed Web of Science ®Google Scholar
• Roberts M, Maskell D, Novotny P, et al. Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect Immun. 1990;58:732–9.
   PubMed Web of Science ®Google Scholar
• Rijpkema SG, Bik EM, Jansen WH, et al. Construction and analysis of a Vibrio cholerae delta-aminolevulinic acid auxotroph which confers protective immunity in a rabbit model. Infect Immun. 1992;60:2188–93.
   PubMed Web of Science ®Google Scholar
• Jackson M, Phalen SW, Lagranderie M, et al. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun. 1999;67:2867–73.
   PubMed Web of Science ®Google Scholar
• Hondalus MK, Bardarov S, Russell R, et al. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun. 2000;68:2888–98. doi:10.1128/IAI.68.5.2888-2898.2000.
   PubMed Web of Science ®Google Scholar
• Priebe GP, Brinig MM, Hatano K, et al. Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine. Infect Immun. 2002;70:1507–17. doi:10.1128/IAI.70.3.1507-1517.2002.
   PubMed Web of Science ®Google Scholar
• Sambandamurthy VK, Wang X, Chen B, et al. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med. 2002;8:1171–4. doi:10.1038/nm765.
   PubMed Web of Science ®Google Scholar
• Buzzola FR, Barbagelata MS, Caccuri RL, et al. Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Infect Immun. 2006;74:3498–506. doi:10.1128/IAI.01507-05.
   PubMed Web of Science ®Google Scholar
• Cava F, Lam H, de Pedro MA, et al. Emerging knowledge of regulatory roles of D-amino acids in bacteria. Cell Mol Life Sci. 2011;68:817–31. doi:10.1007/s00018-010-0571-8.
   PubMed Web of Science ®Google Scholar
• Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS Microbiol Rev. 2008;32:149–67. doi:10.1111/j.1574-6976.2007.00094.x.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Masui R, Akino T. The presence of free D-serine, D-alanine and D-proline in human plasma. Experientia. 1992;48:986–8. doi:10.1007/BF01919147.
   PubMedGoogle Scholar
• Tomasz A.. The staphylococcal cell wall. In: Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J, eds. Gram-positive pathogens. Washington: ASM; 2006.p. 443–55.
   Google Scholar
• Dmitriev BA, Toukach FV, Holst O, et al. Tertiary structure of Staphylococcus aureus cell wall murein. J Bacteriol. 2004;186:7141–8. doi:10.1128/JB.186.21.7141-7148.2004.
   PubMed Web of Science ®Google Scholar
• Neuhaus FC, Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev. 2003;67:686–723. doi:10.1128/MMBR.67.4.686-723.2003.
   PubMed Web of Science ®Google Scholar
• Walsh CT. Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem. 1989;264:2393–6.
   PubMed Web of Science ®Google Scholar
• Scaletti ER, Luckner SR, Krause KL. Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). Acta Crystallogr D Biol Crystallogr. 2012;68:82–92. doi:10.1107/S0907444911050682.
   PubMedGoogle Scholar
• Wasserman SA, Walsh CT, Botstein D. Two alanine racemase genes in Salmonella typhimurium that differ in structure and function. J Bacteriol. 1983;153:1439–50.
   PubMed Web of Science ®Google Scholar
• Wild J, Hennig J, Lobocka M, et al. Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12. Mol Gen Genet. 1985;198:315–22. doi:10.1007/BF00383013.
   PubMedGoogle Scholar
• Thompson RJ, Bouwer HG, Portnoy DA, et al. Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect Immun. 1998;66:3552–61.
   PubMed Web of Science ®Google Scholar
• Tauch A, Gotker S, Puhler A, et al. The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains. J Biotechnol. 2002;99:79–91. doi:10.1016/S0168-1656(02)00159-1.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Henner DJ, Yang MY. Isolation of an alanine racemase gene from Bacillus subtilis and its use for plasmid maintenance in B. subtilis Bio/Technology. 1985;3:1003–7.
   Google Scholar
• Bron PA, Benchimol MG, Lambert J, et al. Use of the alr gene as a food-grade selection marker in lactic acid bacteria. Appl Environ Microbiol. 2002;68:5663–70. doi:10.1128/AEM.68.11.5663-5670.2002.
   PubMed Web of Science ®Google Scholar
• Zajdowicz SL, Jones-Carson J, Vazquez-Torres A, et al. Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker. PLoS One. 2011;6:e21523. doi:10.1371/journal.pone.0021523.
   PubMed Web of Science ®Google Scholar
• Verch T, Pan ZK, Paterson Y. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. Infect Immun. 2004;72:6418–25. doi:10.1128/IAI.72.11.6418-6425.2004.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li Z, Gu B, et al. Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product. Infect Immun. 2005;73:5789–98. doi:10.1128/IAI.73.9.5789-5798.2005.
   PubMed Web of Science ®Google Scholar
• Friedman RS, Frankel FR, Xu Z, et al. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens. J Virol. 2000;74:9987–93. doi:10.1128/JVI.74.21.9987-9993.2000.
   PubMed Web of Science ®Google Scholar
• Grangette C, Muller-Alouf H, Hols P, et al. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect Immun. 2004;72:2731–7. doi:10.1128/IAI.72.5.2731-2737.2004.
   PubMed Web of Science ®Google Scholar
• Kullik I, Jenni R, Berger-Bachi B. Sequence of the putative alanine racemase operon in Staphylococcus aureus: insertional interruption of this operon reduces D-alanine substitution of lipoteichoic acid and autolysis. Gene. 1998;219:9–17. doi:10.1016/S0378-1119(98)00404-1.
   PubMed Web of Science ®Google Scholar
• Cabral MP, Garcia P, Beceiro A, et al. Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy. Nat Commun. 2017;8:15480. doi:10.1038/ncomms15480.
   PubMed Web of Science ®Google Scholar
• Vergara-Irigaray M, Valle J, Merino N, et al. Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections. Infect Immun. 2009;77:3978–91. doi:10.1128/IAI.00616-09.
   PubMed Web of Science ®Google Scholar
• Arnaud M, Chastanet A, Debarbouille M. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol. 2004;70:6887–91. doi:10.1128/AEM.70.11.6887-6891.2004.
   PubMed Web of Science ®Google Scholar
• Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367:731–9. doi:10.1016/S0140-6736(06)68231-7.
   PubMed Web of Science ®Google Scholar
• Fitzgerald JR, Monday SR, Foster TJ, et al. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J Bacteriol. 2001;183:63–70. doi:10.1128/JB.183.1.63-70.2001.
   PubMed Web of Science ®Google Scholar
• Botelho-Nevers E, Verhoeven P, Paul S, et al. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage. Expert Rev Vaccines. 2013;12:1249–59. doi:10.1586/14760584.2013.840091.
   PubMed Web of Science ®Google Scholar
• Pierce KJ, Salifu SP, Tangney M. Gene cloning and characterization of a second alanine racemase from Bacillus subtilis encoded by yncD. FEMS Microbiol Lett. 2008;283:69–74. doi:10.1111/j.1574-6968.2008.01151.x.
   PubMed Web of Science ®Google Scholar
• Pucci MJ, Thanassi JA, Ho HT, et al. Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase. J Bacteriol. 1995;177:336–42. doi:10.1128/jb.177.2.336-342.1995.
   PubMed Web of Science ®Google Scholar
• Steen A, Palumbo E, Deghorain M, et al. Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol. 2005;187:114–24. doi:10.1128/JB.187.1.114-124.2005.
   PubMed Web of Science ®Google Scholar
• Palumbo E, Favier CF, Deghorain M, et al. Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation. FEMS Microbiol Lett. 2004;233:131–8. doi:10.1016/j.femsle.2004.02.001.
   PubMed Web of Science ®Google Scholar
• Rauch S, Gough P, Kim HK, et al. Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection. Infect Immun. 2014;82:4889–98. doi:10.1128/IAI.02328-14.
   PubMed Web of Science ®Google Scholar
• Salgado-Pabon W, Schlievert PM. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat Rev Microbiol. 2014;12:585–91. doi:10.1038/nrmicro3308.
   PubMed Web of Science ®Google Scholar
• Awasthy D, Bharath S, Subbulakshmi V, et al. Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice. Microbiology. 2012;158:319–27. doi:10.1099/mic.0.054064-0.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao X, Higgins DE, et al. Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity. Infect Immun. 2005;73:5065–73. doi:10.1128/IAI.73.8.5065-5073.2005.
   PubMed Web of Science ®Google Scholar
• Stevens TL, Bossie A, Sanders VM, et al. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 1988;334:255–8. doi:10.1038/334255a0.
   PubMed Web of Science ®Google Scholar
• Karauzum H, Datta SK. Adaptive Immunity Against Staphylococcus aureus. Curr Top Microbiol Immunol. 2017;409:419–39. doi:10.1007/82_2016_1.
   PubMed Web of Science ®Google Scholar
• Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell. 1994;76:241–51. doi:10.1016/0092-8674(94)90332-8.
   PubMed Web of Science ®Google Scholar
• Lin L, Ibrahim AS, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009;5:e1000703. doi:10.1371/journal.ppat.1000703.
   PubMed Web of Science ®Google Scholar
• Narita K, Hu DL, Mori F, et al. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A. Infect Immun. 2010;78:4234–42. doi:10.1128/IAI.00447-10.
   PubMed Web of Science ®Google Scholar
• Cho JS, Pietras EM, Garcia NC, et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. 2010;120:1762–73. doi:10.1172/JCI40891.
   PubMed Web of Science ®Google Scholar
• Montgomery CP, Daniels M, Zhao F, et al. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun. 2014;82:2125–34. doi:10.1128/IAI.01491-14.
   PubMed Web of Science ®Google Scholar
• Mancini F, Monaci E, Lofano G, et al. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A. PLoS One. 2016;11:e0147767. doi:10.1371/journal.pone.0147767.
   PubMed Web of Science ®Google Scholar
• Yang L, Cai C, Feng Q, et al. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models. Sci Rep. 2016;6:20929. doi:10.1038/srep20929.
   PubMed Web of Science ®Google Scholar
• Archer NK, Harro JM, Shirtliff ME. Clearance of Staphylococcus aureus nasal carriage is T cell dependent and mediated through interleukin-17A expression and neutrophil influx. Infect Immun. 2013;81:2070–5. doi:10.1128/IAI.00084-13.
   PubMed Web of Science ®Google Scholar
• Joshi A, Pancari G, Cope L, et al. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model. Hum Vaccin Immunother. 2012;8:336–46. doi:10.4161/hv.18946.
   PubMed Web of Science ®Google Scholar
• McNeely TB, Shah NA, Fridman A, et al. Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: an analysis of possible contributing host factors. Hum Vaccin Immunother. 2014;10:3513–6. doi:10.4161/hv.34407.
   PubMed Web of Science ®Google Scholar
• Adhikari RP, Karauzum H, Sarwar J, et al. Novel structurally designed vaccine for S. aureus alpha-hemolysin: protection against bacteremia and pneumonia. PLoS One. 2012;7:e38567. doi:10.1371/journal.pone.0038567.
   PubMed Web of Science ®Google Scholar
• Heim CE, Hanke ML, Kielian T. A mouse model of Staphylococcus catheter-associated biofilm infection. Methods Mol Biol. 2014;1106:183–91. doi:10.1007/978-1-62703-736-5_17.
   PubMedGoogle Scholar
• Kucharikova S, Vande Velde G, Himmelreich U, et al. Candida albicans biofilm development on medically-relevant foreign bodies in a mouse subcutaneous model followed by bioluminescence imaging. J Vis Exp. 2015;95:52239. doi:103791/52239.
   PubMed Web of Science ®Google Scholar